| Date Filed | Type | Description |
| 03/30/2022 |
4
| SHREWSBURY STEPHEN B (Chief Medical Officer) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Exercised 24,606 options to buy
@ $1.97, valued at
$48.5k
|
|
| 01/28/2022 |
4
| SHREWSBURY STEPHEN B (Chief Medical Officer) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Granted 30,000 options to buy
@ $9.85, valued at
$295.5k
|
|
| 09/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2021 |
4
| SHREWSBURY STEPHEN B (Chief Medical Officer) has filed a Form 4 on IMPEL NEUROPHARMA INC|
Txns:
| Granted 50,000 options to buy
@ $12.16, valued at
$608k
|
|
| 04/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/24/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/11/2010 |
4
| SHREWSBURY STEPHEN B (SVP/Regulatory Affairs) has filed a Form 4 on AVI BIOPHARMA INC|
Txns:
| Granted 60,000 options to buy
@ $1.45, valued at
$87k
Granted 120,000 options to buy
@ $1.45, valued at
$174k
|
|
| 01/30/2009 |
4/A
| SHREWSBURY STEPHEN B (SVP/Regulatory Affairs) has filed a Form 4 on AVI BIOPHARMA INC |
| 01/28/2009 |
4
| SHREWSBURY STEPHEN B (SVP/Regulatory Affairs) has filed a Form 4 on AVI BIOPHARMA INC |
| 01/28/2009 |
3
| SHREWSBURY STEPHEN B (SVP/Regulatory Affairs) has filed a Form 3 on AVI BIOPHARMA INC |